Preparation and Characterization of Magnetic Fe3O4/CdWO4 and Fe3O4/CdWO4/PrVO4 Nanoparticles and Investigation of Their Photocatalytic and Anticancer Properties on PANC1 Cells

Materials (Basel). 2019 Oct 8;12(19):3274. doi: 10.3390/ma12193274.

Abstract

Fe3O4/CdWO4 and Fe3O4/CdWO4/PrVO4 magnetic nanoparticles were prepared at different molar ratios of PrVO4 to previous layers (Fe3O4/CdWO4) via the co-precipitation method assisted by a sonochemical procedure, in order to investigate the photocatalytic performance of these systems and their cytotoxicity properties. The physico-chemical properties of these magnetic nanoparticles were determined via several experimental methods: X-ray diffraction, energy dispersive X-ray spectroscopy, Fourier transformation infrared spectroscopy and ultraviolet-visible diffuse reflection spectroscopy, using a vibrating sample magnetometer and a scanning electron microscope. The average sizes of these nanoparticles were found to be in the range of 60-100 nm. The photocatalytic efficiency of the prepared nanostructures was measured by methylene blue degradation under visible light (assisted by H2O2). The magnetic nanosystem with a 1:2:1 ratio of three oxide components showed the best performance by the degradation of ca. 70% after 120 min of exposure to visible light irradiation. Afterwards, this sample was used for the photodegradation of methyl orange, methyl violet, fenitrothion, and rhodamine-B pollutants. Finally, the mechanism of the photocatalytic reaction was examined by releasing ˙OH under UV light in a system including terephthalic acid, as well as O2-, OH, and hole scavengers. Additionally, the cytotoxicity of each synthesized sample was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay against the human cell line PANC1 (cancer), and its IC50 was approximately 125 mg/L.

Keywords: Cytotoxicity properties; Fe3O4/CdWO4; Fe3O4/CdWO4/PrVO4; Human cell line; MTT assay; Magnetic nanoparticle; Methylene blue; PANC1 cells; Photocatalysis; Sonochemical procedure.